Capricor Therapeutics Investors Alerted for Class Action Lawsuit Before Deadline #San_Francisco #class_action_lawsuit #Capricor_Therapeutics #FDA_Review
@newsen.bsky.socialExplore
@newsen.bsky.social@newsen.bsky.socialCapricor Therapeutics Faces FDA Review Delay as Investors Prepare for Class Action Deadline #United_States #San_Francisco #deramiocel #Capricor_Therapeutics #FDA_Review